I have sold quite a few GTOP Dec puts over the last month. Not because I think they will have good results on their upcomming trial data, but because I think the results can't come out that early (and if negative, they will wait till at least the holidays).
So here's the general question. Is it virtually certain that for small biotechs top line P3 data will be delayed for at least a few weeks if it is bad? Is this a playable effect?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.